Eltrombopag Tablet, Film Coated
Product Images NDC 43598-151

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Eltrombopag (NDC 43598-151). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc.,, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton1 (Carton1)

Carton1 (Carton1)
This description provides important information about eltrombopag tablets containing 125 mg of eltrombopag olamine. The usual storage temperature range is 20°C to 25°C with excursions allowed between 15°C to 30°C. Safety closures are recommended for dispensing unless otherwise directed. The product should be kept out of the reach of children. The distributor is Dr. Reddy's Laboratories Inc., based in Princeton, NJ, with the tablets made in India. The tablets should be swallowed whole, not split, chewed, or crushed. Each package contains 30 tablets with 12.5 mg strength and a Medication Guide should be dispensed to each patient.*
FDA Label Image

Carton2 (Carton2)

Carton2 (Carton2)
This text provides information about Eltrombopag Tablets containing eftrombopag olamine equivalent to 25 mg of eltrombopag free acid. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The product is distributed by Dr. Reddy's Laboratories Inc., with the usual dosage available in the accompanying prescribing information. Safety closures should be used during dispensing, and the product should be kept out of the reach of children. The tablets should be swallowed whole and not split, chewed, or crushed. A Medication Guide should be dispensed to each patient by the pharmacist.*
FDA Label Image

Carton3 (Carton3)

Carton3 (Carton3)
This text contains information regarding eltrombopag tablets, each film-coated tablet contains 50 mg of eltrombopag olamine, prescribing information, storage instructions, dosage guidelines, safety precautions, and the recommendation to dispense a Medication Guide to each patient. It also mentions not to split, chew, or crush the tablets. The product is distributed by a company based in Princeton, NJ, with manufacturing in India. The code number and NDC provide further identification details for the tablets.*
FDA Label Image

Carton4 (Carton4)

Carton4 (Carton4)
This is information related to eltrombopag tablets, each film-coated tablet contains 75 mg of the active ingredient. It is advised to store the tablets at a temperature between 20°C to 25°C (68°F to 77°F) but excursions are permitted to 15°C to 30°C (59°F to 86°F). The product is made in India and should only be used as directed by physicians. Safety closures are recommended when dispensing the tablets, and they should be swallowed whole without splitting, chewing, or crushing. The dosage details should be followed as per the accompanying prescribing information, and the medication should be kept out of reach of children. The text mentions a distributor in Princeton, NJ with a specific code number and National Drug Code (NDC) for the product. Pharmacies are instructed to dispense the medication guide to each patient receiving the eltrombopag tablets.*
FDA Label Image

Container1 (Container1)

FDA Label Image

Container2 (Container2)

FDA Label Image

Container3 (Container3)

FDA Label Image

Container4 (Container4)

FDA Label Image

Structure (Structure)

FDA Label Image

Symbol (Symbol)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.